Anti-CDC42 binding protein kinase alpha antibody (ab96659)

Publishing research using ab96659? Please let us know so that we can cite the reference in this datasheet.

ab96659 has been referenced in 1 publication.

  • Zhu KC  et al. Afzelin exhibits anti-cancer activity against androgen-sensitive LNCaP and androgen-independent PC-3 prostate cancer cells through the inhibition of LIM domain kinase 1. Oncol Lett 10:2359-2365 (2015). WB ; Human . PubMed: 26622852

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"